MIURA-D INJ

MIURA-D INJ contains Vitamin D3 (cholecalciferol) as its active ingredient. It is a fat-soluble vitamin that plays a crucial role in maintaining optimal bone health and regulating calcium and phosphorus metabolism in the body.

Mechanism of Action:

Vitamin D3 is converted into its active form, calcitriol, in the body. Calcitriol binds to vitamin D receptors in various tissues, including the intestines, bones, kidneys, and parathyroid glands. It regulates calcium and phosphorus absorption in the intestines, promotes bone mineralization by stimulating osteoblast activity, and helps maintain normal serum calcium levels.

Uses:

MIURA-D INJ is indicated for the prevention and treatment of vitamin D deficiency, which can lead to conditions such as rickets in children and osteomalacia in adults. It is also used as an adjunctive therapy in the management of certain bone disorders, including osteoporosis.

Dosage and Administration:

The dosage of MIURA-D INJ varies depending on the age, severity of deficiency, and individual patient factors. It is typically administered as an intramuscular injection under the guidance of a healthcare professional. The recommended dosage may range from a single injection of 300,000 IU to several injections over a specified period.

Side Effects:

Common side effects associated with MIURA-D INJ may include:

• Nausea
• Vomiting
• Constipation
• Fatigue
• Muscle weakness
• Increased thirst
• Metallic taste in the mouth

Precautions:

• MIURA-D INJ should be used with caution in patients with hypercalcemia, hypervitaminosis D, or conditions predisposing to hypercalcemia, such as primary hyperparathyroidism or sarcoidosis.
• Patients with renal impairment may require dose adjustments or monitoring of serum calcium and phosphorus levels during treatment with MIURA-D INJ.
• Long-term use of high doses of vitamin D should be avoided without appropriate medical supervision, as it may lead to vitamin D toxicity and hypercalcemia.
• Patients should be advised to maintain an adequate intake of dietary calcium and to avoid excessive sun exposure while receiving treatment with MIURA-D INJ.

Conclusion:

MIURA-D INJ, containing Vitamin D3, is used for the prevention and treatment of vitamin D deficiency and related bone disorders. By regulating calcium and phosphorus metabolism and promoting bone mineralization, vitamin D3 helps maintain optimal bone health. However, it is essential to use this medication cautiously and under the guidance of a healthcare professional to avoid potential side effects and complications.